Lucio Iannone is an experienced Head of Health Venture Investments at Leaps by Bayer, with a strong background in biotechnology and a passion for advancing innovative therapies. He serves on multiple boards, driving groundbreaking research in cancer therapeutics and gene editing technologies. Lucio's expertise in venture investments and strategic decision-making has led to successful collaboration...